Blacks and Latinos, hit hardest by the COVID-19 pandemic, are woefully underrepresented during clinical trials for novel drugs according to a report by the Tufts Center of Drug Development. The U.S. Food and Drug Administration emphasized that the lack of diverse...
The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) received a $24.3 million Clinical and Translational Science Award from the National Center for Advancing Translational Science—part of the National Institutes of Health (NIH)....
Upon the advent of the COVID-19 pandemic and all that has come along with this unprecedented event, Temple University Hospital has significantly responded with a diversified clinical research program—including participation in a variety of clinical trials that are...
As the COVID-19 pandemic sweeps through America, Black populations, already vulnerable to a host of social determinant of health indicators, are disproportionately hit hard in a disturbing trend where observers indicate African Americans die at far higher rates than...
In a workshop held by the FDA in partnership with the American Association for Cancer Research (AACR) on February 13, 2019 in Wardman Park, Washington D.C., researchers from various institutions discussed the current state of African American outcomes and treatment in...
The Deep South Resource Center for Minority Aging Research onboards Reagan W. Durant, MD, associate professor at the University of Alabama at Birmingham’s Division of Preventative Medicine. Dr. Durant will serve as a new principal investigator. The Deep South RCMAR A...
